rts logo

These Numbers Show Favorable Signs for CVS Health Corp (CVS)

CVS Health Corp (NYSE: CVS) is -6.51% lower on its value in year-to-date trading and has touched a low of $64.41 and a high of $83.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CVS stock was last observed hovering at around $79.56 in the last trading session, with the day’s loss setting it -5.74%.

Currently trading at $73.82, the stock is -4.12% and -2.65% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 23.67 million and changing -7.21% at the moment leaves the stock 1.74% off its SMA200. CVS registered -1.18% loss for a year compared to 6-month gain of 5.73%. The firm has a 50-day simple moving average (SMA 50) of $0.45 and a 200-day simple moving average (SMA200) of $8.84.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The stock witnessed a -0.03% loss in the last 1 month and extending the period to 3 months gives it a -6.51%, and is -6.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.34% over the week and 2.05% over the month.

CVS Health Corp (CVS) has around 300000 employees, a market worth around $92.90B and $358.27B in sales. Current P/E ratio is 11.42 and Fwd P/E is 8.02. Profit margin for the company is 2.33%. Distance from 52-week low is 14.61% and -11.33% from its 52-week high. The company has generated returns on investments over the last 12 months (5.52%).

CVS Health Corp quarterly earnings per share for the current quarter are estimated at $1.71 with sales reaching $89.24B over the same period.The EPS is expected to shrink by -5.10% this year, but quarterly earnings will post 3.60% year-over-year. Quarterly sales are estimated to grow 10.40% in year-over-year returns.

CVS Health Corp (CVS) Top Institutional Holders

2,787 institutions hold shares in CVS Health Corp (CVS), with institutional investors hold 83.14% of the company’s shares. The shares outstanding are 1.29B, and float is at 1.26B with Short Float at 1.48%. Institutions hold 83.05% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 116.68 million shares valued at $8.07 billion. The investor’s holdings represent 9.08% of the CVS Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 93.73 million shares valued at $6.48 billion to account for 7.30% of the shares outstanding. The other top investors are State Street Corporation which holds 55.88 million shares representing 4.35% and valued at over $3.86 billion, while Morgan Stanley holds 2.59% of the shares totaling 33.25 million with a market value of $2.3 billion.

CVS Health Corp (CVS) Insider Activity

The most recent transaction is an insider sale by Shah Prem S,the company’sEVP and Pres-Pharm, Consumer W. SEC filings show that Shah Prem S sold 29,473 shares of the company’s common stock on Feb 16 ’24 at a price of $76.95 per share for a total of $2.27 million. Following the sale, the insider now owns 39765.0 shares.

CVS Health Corp disclosed in a document filed with the SEC on Nov 03 ’23 that LUDWIG EDWARD J (Director) bought a total of 2,000 shares of the company’s common stock. The trade occurred on Nov 03 ’23 and was made at $70.47 per share for $0.14 million. Following the transaction, the insider now directly holds 20630.0 shares of the CVS stock.

Still, SEC filings show that on Aug 03 ’23, Clark James David (SVP, Cont & Chief Acct Officer) disposed off 25,759 shares at an average price of $74.92 for $1.93 million. The insider now directly holds 4,698 shares of CVS Health Corp (CVS).

Related Posts